Gulf Medical Projects Company (PJSC)'s (ADX:GMPC) Risks Elevated At These Prices

Gulf Medical Projects Company (PJSC)'s (ADX:GMPC) price-to-earnings (or "P/E") ratio of 23.2x might make it look like a strong sell right now compared to the market in the United Arab Emirates, where around half of the companies have P/E ratios below 10x and even P/E's below 6x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.

For example, consider that Gulf Medical Projects Company (PJSC)'s financial performance has been poor lately as it's earnings have been in decline. One possibility is that the P/E is high because investors think the company will still do enough to outperform the broader market in the near future. If not, then existing shareholders may be quite nervous about the viability of the share price.

View our latest analysis for Gulf Medical Projects Company (PJSC)

Advertisement

How Does Gulf Medical Projects Company (PJSC)'s P/E Ratio Compare To Its Industry Peers?

We'd like to see if P/E's within Gulf Medical Projects Company (PJSC)'s industry might provide some colour around the company's particularly high P/E ratio. You'll notice in the figure below that P/E ratios in the Healthcare industry are also significantly higher than the market. So this certainly goes a fair way towards explaining the company's ratio right now. In the context of the Healthcare industry's current setting, most of its constituents' P/E's' P/E's would be expected to be raised up greatly. We'd highlight though, the spotlight should be on the anticipated direction of the company's earnings.

ADX:GMPC Price Based on Past Earnings July 7th 2020
ADX:GMPC Price Based on Past Earnings July 7th 2020
Although there are no analyst estimates available for Gulf Medical Projects Company (PJSC), take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.

How Is Gulf Medical Projects Company (PJSC)'s Growth Trending?

The only time you'd be truly comfortable seeing a P/E as steep as Gulf Medical Projects Company (PJSC)'s is when the company's growth is on track to outshine the market decidedly.

Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 40%. As a result, earnings from three years ago have also fallen 95% overall. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.

This is in contrast to the rest of the market, which is expected to decline by 23% over the next year, or less than the company's recent medium-term annualised earnings decline.

In light of this, it's odd that Gulf Medical Projects Company (PJSC)'s P/E sits above the majority of other companies. With earnings going quickly in reverse, it's not guaranteed that the P/E has found a floor yet. Maintaining these prices will be extremely difficult to achieve as a continuation of recent earnings trends is likely to weigh down the shares eventually.

The Key Takeaway

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that Gulf Medical Projects Company (PJSC) currently trades on a much higher than expected P/E since its recent three-year earnings are even worse than the forecasts for a struggling market. Right now we are increasingly uncomfortable with the high P/E as this earnings performance is unlikely to support such positive sentiment for long. In addition, we would be concerned whether the company can even maintain its medium-term level of performance under these tough market conditions. Unless the company's relative performance improves markedly, it's very challenging to accept these prices as being reasonable.

There are also other vital risk factors to consider and we've discovered 3 warning signs for Gulf Medical Projects Company (PJSC) (1 is concerning!) that you should be aware of before investing here.

If you're unsure about the strength of Gulf Medical Projects Company (PJSC)'s business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

When trading Gulf Medical Projects Company (PJSC) or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.Promoted


New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

MI
mitchell_lawler
mitchell_lawler

Druckenmiller says cheap money's days are numbered. Boring, self-funding companies could be the opportunity.

Druckenmiller says cheap money's days are numbered. Boring, self-funding companies could be the opportunity. cover
1311
DE
devon_jd150

Leverage on its own is close to useless as a screen right now, because so much corporate debt was termed out at 2 to 3% and has not repriced. A business at three times leverage with nothing due until 2031 is in a completely different position from the same ratio rolling next year. Screen on weighted average maturity and the schedule behind it.

LE
LeverageIsLovely

In my view, Insurance companies are best positioned for this.

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
32

About ADX:GMPC

Gulf Medical Projects Company (PJSC)

Manages hospitals in the United Arab Emirates.

Flawless balance sheet with acceptable track record.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$522.8% undervalued
67 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.7% undervalued
47 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
31 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11630.7% undervalued
7 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3527.7% undervalued
27 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LU
LunaRodas
DKS logo
LunaRodas on DICK'S Sporting Goods ·

DKS | DICK'S Sporting Goods: What They Said vs. What They Did

Fair Value:US$112.7710.2% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
prajeeshprathap
MEDP logo
prajeeshprathap on Medpace Holdings ·

Why Medpace Outperforms Competitors in the Mid-Sized Biotech Niche

Fair Value:US$53614.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.9% undervalued
354 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9117.1% overvalued
202 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.1% undervalued
228 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0